LUMO - Lumos Pharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-27.09M

Cash

57.98M

Avg Qtr Burn

-6.947M

Short % of Float

3.00%

Insider Ownership

38.43%

Institutional Own.

30.03%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LUM-201 (Ibutamoren) Details Pediatric growth hormone deficiency Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LUM-201 (Ibutamoren) Details Thyroid Eye Disease	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LUM-201 (Ibutamoren) Details Turner syndrome	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.